Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction

BACKGROUND: This study aimed to investigate intracoronary nicorandil treatment on the no-reflow phenomenon (NRP) during primary percutaneous coronary intervention (PCI) in patients with acute ST-segment elevation myocardial infarction (STEMI) and to compare nicorandil with sodium nitroprusside. MATE...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Med Sci Monit
Главные авторы: Qi, Qi, Niu, Jinghui, Chen, Tao, Yin, Hongshan, Wang, Tao, Jiang, Zhian
Формат: Artigo
Язык:Inglês
Опубликовано: International Scientific Literature, Inc. 2018
Предметы:
Clinical Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5954842/
https://ncbi.nlm.nih.gov/pubmed/29726480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.906815
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы